Effect of Astaxanthin in treatment of PCOS

Phase 3

Recruiting

• Conditions: Polycystic Ovarian Syndrome.; Polycystic ovarian syndrome; E28.2

• Registration Number: IRCT20201029049183N2
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 2 May 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Oligo/anovulation (ovulationabnormality)
Hyperandrogenism
Polycystic ovaries on ultrasound

Exclusion Criteria

Pregnancy
Adrenal hyperplasia
Androgen-secretingtumors
Hyperprolactinemia
Thyroid dysfunction
Diabetes mellitus or glucose tolerance
Male infertility factors

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ER stress and apoptotic factor. Timepoint: Before and 60 days after the intervention. Method of measurement: real time pcr.;Plasma inflammatory factors. Timepoint: Before and 60 days after the intervention. Method of measurement: ELISA KIT.